Summary A recent trial by the MRC Lung Cancer Working Party used physician assessments to compare two palliative schedules of radiotherapy in lung cancer. A prospective study has been undertaken on a subset of these trial patients to see how physician assessments of symptomatic relief and general condition correlate with patient perception of therapeutic response. In 40 patients followed up monthly from presentation until close to death, good agreement was found between doctors and patients on change in specific physical symptoms and overall physical condition. Doctors were poor judges of life quality at presentation but appeared able to identify relative improvement or deterioration in overall quality of life. In conclusion, physician assessments may constitute valid end-points for radiotherapy trials comparing palliative schedules in lung cancer.
Radiotherapy is often used of the palliation of respiratory systems and pain in patients with inoperable non-small cell lung cancer (NSCLC) but published data relating to treatment benefit are based on retrospective physician assessments of individual symptoms rather than on prospective patient self-assessments (Deeley et al., 1967; Durrant et al., 1971; Slawson et al., 1979; Simpson et al., 1985) .
A recent trial by the MRC Lung Cancer Working Party compared two schedules of palliative radiotherapy (ten treatments vs two treatments) in symptomatic patients. The results were based on physician ratings of symptomatic relief and detected no differences in treatment outcome (Lung Cancer Working Party, 1991) . However, it is unclear how well physician ratings of response correlate with patients' views of treatment benefit. In an attempt to measure the utility of physician ratings as a basis for comparing palliative radiotherapy schedules in lung cancer, a prospective study was undertaken of physician and patient assessments before and after radiotherapy for lung cancer. (Aaronson et al., 1988) . The first visit lasted anything up to 1 h, giving the patient ample opportunity to express him or herself and to become familiar with the structure of the questionaire. Every patient complied fully at every clinic visit where they spent as Figure 3 .
Patients and methods
Correlation between physician and patient assessments at presentation None of the physician assessments correlated with patient self-ratings of overall life quality (Table I) . On the other hand, there were significant correlations between patient selfassessments of overall physical condition and physician assessments of physical performance, general condition, dyspnoea (Table I) . Patient self-ratings of overall life quality did not correlate with any of the physician assessments (Table I) . There was also a high correlation between patient self-assessments of overall life quality and overall physical condition (r = 0.74; P < 0.001). majority of patients at 1 month following radiotherapy (Figure 4) . In those patients surviving to 3 months, over 40% were judged to have improved in terms of performance status and general condition, although few were judged to be less breathless (Figure 4 ). In contrast, improvements in specific symptoms were recorded at 1 month and at 3 months ( Figure   5 ).
Patient's assessments of treatment response Scores for overall life quality and overall physical state showed an improvement in about half of the patients 1 month after presentation, while just under a quarter showed a deterioration ( Figure 6 ). There was a small but significant association between changes in the patient assessments of breathlessness and changes in patient assessments of overall life quality (Table II) .
Relationship between changes in physician and patient assessments after I month Physician ratings of overall condition judged from the question 'Does the patient in general feel better, the same, or worse than at last attendance?' are displayed in Figure 6 . Responses to this question showed a pattern of change similar to that obtained from the patient assessment of change in overall life quality and overall physical state ( Figure 6 ). Change in the patient ratings of overall life quality was significantly associated with physician assessments of 'how the patient feels compared to the last visit' (Table III) . Changes in the patient self-assessment of breathlessness were significantly related to changes in the physician assessments of MRC respiratory status at 1 month, but not with change in physician ratings of ECOG performance status (Tables IV  and V) . fractions and 17 Gy in two fractions to the thorax in patients with incurable non-small cell lung cancer (Bleehen et al., 1990) . The main comparisons were based on monthly assessments of symptoms and performance status as recorded by their physicians. The present study was undertaken on a subset of the MRC trial patients to test whether ratings by physicians provided a reliable measure of the patient's subjective state of health in a trial of palliative radiotherapy. This was done by comparing physician ratings and patient self-assessments of therapeutic response. The pre-treatment characteristics of 40 patients in the current study were comparable to 369 patients randomised in the MRC study: males 82% (MRC 78%), median age 68 years (MRC 68 years), distant metastases 23% (MRC 32%), ECOG performance status 0 or 1 61.5% (MRC 51%), haemoptysis 42.5% (MRC 46.5%), cough 90% (MRC 92.5%), chest pain 37.5% (MRC 46.5%). In our patients, physicians scored improved ratings for haemoptysis in 75% (MRC 81%), cough in 50% (MRC 65%) and chest pain in 80% (MRC 75%). The median survival was 22 weeks, compared with 24 weeks for patients in the MRC study. Our study population appears, therefore, to have been a representative sub-set of the patients in the whole study. The mortality rate in the study severely limited the time period over which comparisons could be made between physicians' and patients' estimates of the patients' health. We have mainly concentrated on changes over the first month of follow-up after treatment.
At presentation, there was significant agreement between the patient assessments of overall physical condition and the physician assessments of ECOG performance status, MRC general condition and MRC respiratory status (Table II) . Similarly, there was a signficant agreement between change in respiratory status assessed by the physicians using the MRC dyspnoea scale and change in breathlessness scored by the patients using the EORTC questionnaire (Table III ). In contrast, there was poor agreement at presentation between the patient assessments of overall life quality and any of the physician assessments (Table I) . Furthermore, changes in patient rating of overall life quality did not correlate with changes in the physician assessments, such as ECOG performance status (Table V) . The inability of physicians to accurately estimate the life quality of their patients has been previously reported (Slevin et al., 1988) . In our study, the data presented in Table IV shows a weak, but significant correlation between patient ratings of changes in overall life quality at 1 month compared with physician ratings of 'how the patient feels compared to the last visit'. These data may be interpreted to suggest that physicians were able to recognise relative change in life quality. The reason for this apparent sensitivity to changes in the patients' overall life quality may be related to a particular item in the MRC questionnaire completed by physicians. The form of this item 'how the patient feels compared to the last visit' (the same, better or worse) is unique in terms of its global nature relative to other assessments such as ECOG performance status and MRC respiratory scale. The physician is able to gather information about how the patient actually feels by asking the question directly. More work is needed to find out if this particular assessment correlates well with patient self-assessments of change in life quality.
In conclusion, this small but detailed study suggests there is reasonable agreement between doctors and patients on the latter's overall physical condition at the time of presentation with inoperable NSCLC. There was also a measure of agreement concerning changes in these parameters. The study suggests that physicians are poor judges of the overall life quality of their patients at presentation. Physicians do appear to have some measure of success in detecting relative changes in patient overall life quality following palliative radiotherapy although this may rely heavily on the nature of a particular questionnaire item. It is therefore reasonable to assume that physician assessments of changes in specific symptoms and physical status before and after treatment constitute valid endpoints for radiotherapy trials comparing palliative schedules in inoperable lung cancer.
